Kazia Therapeutics
KZIA
5 hedge funds and large institutions have $41K invested in Kazia Therapeutics in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
17% less funds holding
Funds holding: 6 → 5 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
67% less capital invested
Capital invested by funds: $123K → $41K (-$82K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BWFA
Baltimore-Washington Financial Advisors
Columbia,
Maryland
|
+$781 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$68K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.03K |
| 3 |
U
UBS
Zurich,
Switzerland
|
-$2.34K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Bank of America
Charlotte,
North Carolina
| $35K | – | – | – |
|
|
U
2
UBS
Zurich,
Switzerland
| $4K | -$2.34K | -3 | -43% |
|
3
Creative Planning
Overland Park,
Kansas
| $1K | – | – | – |
|
|
PP
4
Palladium Partners
Norfolk,
Virginia
| $1K | – | – | – |
|
|
5
Renaissance Technologies
New York
| – | -$68K | -76 | Closed |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| – | -$7.03K | -9 | Closed |
|
|
BWFA
7
Baltimore-Washington Financial Advisors
Columbia,
Maryland
| – | +$781 | +1 | New |
|
KZIA Hedge Fund Activity: Q3 2013 in Review
5 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q3 2013, worth a combined $41K — down 67% from $123K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of KZIA and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Baltimore-Washington Financial Advisors, opening a new position worth an estimated $781. The largest seller was Renaissance Technologies, exiting entirely with an estimated $68K sold.
- 5 institutional investors held Kazia Therapeutics (KZIA) as of Q3 2013, down from 6 in Q2 2013.
- Funds reported $41K of Kazia Therapeutics stock for Q3 2013, down 67% quarter-over-quarter.
- 1 fund opened new Kazia Therapeutics positions in Q3 2013 and 2 closed out, a net change of -1 holder.
- The largest Kazia Therapeutics buyer in Q3 2013 was Baltimore-Washington Financial Advisors, an estimated $781 added.
- The largest Kazia Therapeutics seller in Q3 2013 was Renaissance Technologies, an estimated $68K sold.
Based on aggregated 13F filings for Q3 2013.